Zacks Investment Research·Sep 16, 2026
Here's Why You Should Retain CONMED Stock in Your Portfolio for NowCONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.
CONMED's fundamental outlook is anchored on a resilient, asset-light surgical franchise that has demonstrated margin recovery to a 57.5% gross margin in 2026Q2 after a 2025Q3 disruption, yet the company's earnings remain highly volatile, with EPS swinging from...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 29, 2026 | $1.38+24.3% vs $1.11 | $343M+1.7% vs $338M |
Q2 2026 Apr 29, 2026 | $0.89+8.5% vs $0.82 | $317M+2.1% vs $311M |
Q1 2026 Jan 28, 2026 | $1.43+8.3% vs $1.32 | $373M+1.7% vs $367M |
Q4 2025 Nov 5, 2025 | $1.08+2.9% vs $1.05 | $338M-7.9% vs $367M |
CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.
Canada Pension Plan Investment Board purchased a new position in CONMED Corporation (NYSE: CNMD) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 13,800 shares of the company's stock, valued at approximately $452,000. Other institutional investors also recently modified
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the Encore Boston Harbor in Everett, MA. Management will participate in a fireside chat on Wednesday, September 9th at 1:30 p.m. Eastern Time. A live audio webcast of the fireside chat will be accessible under the “Events” section of the company's investor relations website: https://www.conmed.com/en/inv.
Benchmark CNMD against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for CONMED Corporation (CNMD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $45.80 | $1.37B | 30.33 | 5.16% | 3.42% | 4.72% | 1.73% | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — | |
| $59.96 | $3.05B | -249.81 | 14.88% | 1.85% | 2.14% | — | |
| $16.25 | $1.88B | -13.32 | 8.28% | -21.25% | -44% | — | |
| $87.07 | $5.19B | 40.88 | 11.66% | 9.22% | 9.07% | — | |
| $80.58 | $1.84B | 31.98 | 13.53% | 25.02% | 16.42% | — |
CONMED Corporation (CNMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
CONMED Corporation (CNMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 29, 2026·SEC
Jun 17, 2026·SEC
Jun 4, 2026·SEC
Get notified when CNMD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CONMED Corporation (CNMD) stock FAQ — growth, dividends, profitability & financials explained
CONMED Corporation (CNMD) reported $1.37B in revenue for fiscal year 2025. This represents a 993% increase from $125.6M in 1996.
CONMED Corporation (CNMD) grew revenue by 5.2% over the past year. This is steady growth.
Yes, CONMED Corporation (CNMD) is profitable, generating $56.5M in net income for fiscal year 2025 (3.4% net margin).
Yes, CONMED Corporation (CNMD) pays a dividend with a yield of 1.73%. This makes it attractive for income-focused investors.
CONMED Corporation (CNMD) has a return on equity (ROE) of 4.7%. This is below average, suggesting room for improvement.
CONMED Corporation (CNMD) generated $134.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
